id,group_id,source,exact,prefix,suffix,anno_type,position_type,start,end,tags,all,origin_tags,comment,user,title,created
zDpb6sTLEemlY6feU8ayuQ,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Renal impairment stage I,"ration rate (GFR) ml/min/1.73m2
", (GFR ≥90) n (%)199 (26.8)228 (3,TextQuoteSelector,TextPositionSelector,22649,22673,WS_DS,no,WS_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:58:39.226358+00:00
vplruMTJEemlYsf3lshBmw,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Amylin,"se Inhibitors, n (%)0 (0)1 (0.1)"," analogues, n (%)0 (0)0 (0)Incre",TextQuoteSelector,TextPositionSelector,23782,23788,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:43:57.384672+00:00
vaSPXMTKEemJtvf1zuQiOw,3NabqAPM,https://europepmc.org/articles/PMC4540425/,overactive bladder,"= 33%; PGISS baseline, Previous "," therapy (Y/N) = 28%; Qmax, ED d",TextQuoteSelector,TextPositionSelector,25041,25059,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:51:05.387855+00:00
u6BaPMTLEemgi0f2kTLZkg,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Renal impairment,"scular disorder, n (%)0 (0)0 (0)", Glomerular filtration rate (GFR,TextQuoteSelector,TextPositionSelector,22585,22601,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:58:11.427913+00:00
skVH8MTKEemfwGvyI5wB4w,3NabqAPM,https://europepmc.org/articles/PMC4540425/,psychotic,"ypertensive drugs, cluster anti-"," drugs, cluster anti-diabetic dr",TextQuoteSelector,TextPositionSelector,24534,24543,WT_DS,no,[WT_DS],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:50:46.241626+00:00
s9U9GsTJEem3L5-7njJZ1A,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Alpha-glucosidase,"onylureas, n (%)28 (3.7)36 (4.8)"," Inhibitors, n (%)0 (0)1 (0.1)Am",TextQuoteSelector,TextPositionSelector,23735,23752,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:43:39.426552+00:00
s6E-_ssREemJyXPI6ga7xA,3NabqAPM,https://europepmc.org/articles/PMC4540425/,"erectile dysfunction; IPSS, International Prostate Symptom Score; MCID, Minimal Clinically Important Differences; N, no; PSA, prostate specific antigen","nt.CI, confidence interval; ED, ","; ROC, Receiver Operating Curve;",TextQuoteSelector,TextPositionSelector,37765,37916,NGD,no,NGD,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-30T10:34:09.687851+00:00
qqXgXsTKEemJTSNAcnxvPg,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Hypertension,"101 (13.4)
Treatment compliance
"," treatment phase, n (%)285 (38.2",TextQuoteSelector,TextPositionSelector,24074,24086,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:50:33.389488+00:00
qlut0MTLEemJU5MUqiQr8w,3NabqAPM,https://europepmc.org/articles/PMC4540425/,PSA,", or prostate-specific antigen (",) predicted prostate volume (≤40,TextQuoteSelector,TextPositionSelector,14009,14012,MIS_GP,yes,[MIS_GP][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:57:42.329151+00:00
qPCqfsTJEemUfas6stqkSA,3NabqAPM,https://europepmc.org/articles/PMC4540425/,31.1,"(2.1)17 (2.3)BMI ≥30, n (%)232 (",")173 (23.0)Mean BMI (SD), kg/m22",TextQuoteSelector,TextPositionSelector,19495,19499,WT_GP,no,[WT_GP],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:43:20.998024+00:00
odraasTKEem2368eB_2_rg,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Dipeptidyl peptidase 4,"retin mimetics, n (%)0 (0)2 (0.3"," inhibitors, n (%)2 (0.3)6 (0.8)",TextQuoteSelector,TextPositionSelector,23850,23872,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:50:18.678569+00:00
o8U_zMTLEemTev96PBiMUg,3NabqAPM,https://europepmc.org/articles/PMC4540425/,prostate-specific antigen,"rone level (<300/≥300ng/dl), or ", (PSA) predicted prostate volume,TextQuoteSelector,TextPositionSelector,13982,14007,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:57:31.362685+00:00
nUXHzssREemw3Y-psMT9Sw,3NabqAPM,https://europepmc.org/articles/PMC4540425/," BPH Impact Index; CI, confidence interval; ED, erectile dysfunction; IIEF, International Index of Erectile Function; IPSS, International Prostate Symptom Score; N, no; PGI-I, Patient Global Impression of Improvement; PGISS, Patient Global Incontinence Severity Score; QoL, quality of life; ROC, Receiver Operating Curve; SHBG, sex hormone binding globulin","ptor blockers and diuretics.BII,","; Y, yes.A reduction of ≥1 point",TextQuoteSelector,TextPositionSelector,44266,44622,NGD,no,NGD,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-30T10:33:32.313281+00:00
mEUe7MTLEemJrr80ptAIGQ,3NabqAPM,https://europepmc.org/articles/PMC4540425/,prostate specific antigen,"ortant Differences; N, no; PSA, ","; ROC, Receiver Operating Curve;",TextQuoteSelector,TextPositionSelector,37904,37929,CRT_GP,yes,[CRT_GP][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:57:11.906778+00:00
kEZHQssREemh8gcLLpLGfg,3NabqAPM,https://europepmc.org/articles/PMC4540425/,"BPH Impact Index; CI, confidence interval; DT, Decision Tree; IPSS, International Prostate Symptom Score; MCID, Minimally Clinically Important Differences; PGI-I, Patient Global Impression of Improvement; PSA, prostate specific antigen; Qmax, maximal flow rate; QoL, quality of life; RF, Random Forest; SHBG, sex hormone binding globulin","SHBG, Albumin, PGI, and PSABII, ",.Go to:DiscussionIdentifying pre,TextQuoteSelector,TextPositionSelector,49312,49649,NGD,no,NGD,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-30T10:33:10.282023+00:00
jwdbesTKEem_2CffiqV9qA,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Monoamine oxidase,"depressants, n (%)1 (0.1)1 (0.1)"," inhibitors, n (%)0 (0)0 (0)Anti",TextQuoteSelector,TextPositionSelector,23483,23500,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:49:47.074790+00:00
jX6pJMTLEemVi6-tU8Ihhw,3NabqAPM,https://europepmc.org/articles/PMC4540425/,prostate malignancy,">10ng/ml (or for PSA 4–10ng/ml, "," had to be excluded), if post-vo",TextQuoteSelector,TextPositionSelector,17796,17815,WS_DS,no,WS_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:56:53.992628+00:00
gi7yBMTLEemJUnsJq7OAiA,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Ischaemic heart disease,".3)Vasculitis, n (%)0 (0)3 (0.4)",", n (%)44 (5.9)43 (5.7)Myocardia",TextQuoteSelector,TextPositionSelector,21819,21842,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:56:34.971416+00:00
fqKJxsTKEemJS-cvVHif8Q,3NabqAPM,https://europepmc.org/articles/PMC4540425/, vascular disorder,(%)18 (2.4)17 (2.3)Miscellaneous,", n (%)20 (2.7)13 (1.7)Other vas",TextQuoteSelector,TextPositionSelector,22406,22424,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:49:19.435100+00:00
d_z6sMTLEemMtVdtCKsljw,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Incontinence,"rovement; PGISS, Patient Global "," Severity Score; QoL, quality of",TextQuoteSelector,TextPositionSelector,44519,44531,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:56:17.993268+00:00
dHusrMTKEemmXXNlc0wIJg,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Peripheral vascular thrombosis," disorder, n (%)11 (1.5)10 (1.3)"," or embolism, n (%)18 (2.4)17 (2",TextQuoteSelector,TextPositionSelector,22328,22358,WS_DS,no,WS_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:49:02.499974+00:00
chBEssTHEem_5duQ-hLKFg,3NabqAPM,https://europepmc.org/articles/PMC4540425/,BPH,o benign prostatic hyperplasia (,) achieve clinically meaningful ,TextQuoteSelector,TextPositionSelector,9444,9447,MIS_DS,yes,[MIS_DS][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:27:29.960031+00:00
cgrImMTMEemTLaenIwvJrg,3NabqAPM,https://europepmc.org/articles/PMC4540425/,calcium channels," α-blocking agents, β-blockers, "," blockers, angiotensin convertin",TextQuoteSelector,TextPositionSelector,25425,25441,MIS_GP,yes,[MIS_GP][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T11:03:17.398742+00:00
bXc_9sTLEemTJmsOgnwoAA,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Hyperlipidaemia,"nsion, n (%)288 (38.6)300 (39.9)",", n (%)152 (20.3)183 (24.3)Vascu",TextQuoteSelector,TextPositionSelector,21748,21763,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:56:00.086017+00:00
bUdvbsTHEemgfqsJShnYOw,3NabqAPM,https://europepmc.org/articles/PMC4540425/,benign prostatic hyperplasia,ct symptoms (LUTS) secondary to , (BPH) achieve clinically meanin,TextQuoteSelector,TextPositionSelector,9414,9442,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:27:22.041139+00:00
_LuqGMTKEemXQxsFq20-eg,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Cardiovascular disorders,"dications*48 (41, 56)66 (56, 75)"," cluster57 (49, 64)58 (48, 68)St",TextQuoteSelector,TextPositionSelector,40876,40900,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:52:51.044051+00:00
ZwRVfsTKEemXQaMdX-iWdA,3NabqAPM,https://europepmc.org/articles/PMC4540425/, cerebrovascular disorders,"ders, n (%)11 (1.5)10 (1.3)Other",", n (%)1 (0.1)0 (0)Any cerebrova",TextQuoteSelector,TextPositionSelector,22232,22258,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:48:39.891223+00:00
Ze41kMTMEemJuT_kqKfoEw,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Calcium channel,"ockers, n (%)92 (12.3)114 (15.2)"," blockers, n (%)76 (10.2)68 (9.0",TextQuoteSelector,TextPositionSelector,22968,22983,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T11:02:57.111520+00:00
YlgMLMTLEembvss9a0odWQ,3NabqAPM,https://europepmc.org/articles/PMC4540425/, embolism,eripheral vascular thrombosis or,", n (%)18 (2.4)17 (2.3)Miscellan",TextQuoteSelector,TextPositionSelector,22361,22370,WT_DS,no,[WT_DS],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:55:41.686194+00:00
YasbMMTKEemA-U_jUYl5fw,3NabqAPM,https://europepmc.org/articles/PMC4540425/,cerebrovascular disorder,"disorders, n (%)1 (0.1)0 (0)Any ",", n (%)11 (1.5)10 (1.3)Periphera",TextQuoteSelector,TextPositionSelector,22281,22305,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:48:31.067210+00:00
WYGcsMTIEemMojNqztCR9g,3NabqAPM,https://europepmc.org/articles/PMC4540425/,PDE-5,"erectile dysfunction (ED), with ", inhibitors and notably tadalafi,TextQuoteSelector,TextPositionSelector,12256,12261,MIS_GP,yes,[MIS_GP][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:33:58.351274+00:00
WJsixMTKEemTdDfZvBQg3w,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Ischaemic cerebrovascular disorders,"r disorders, n (%)7 (0.9)5 (0.7)",", n (%)11 (1.5)10 (1.3)Other cer",TextQuoteSelector,TextPositionSelector,22169,22204,WS_DS,no,WS_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:48:15.674228+00:00
WFIdxsTLEem25Js5zCm26w,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Diabetes mellitus,".21)41.02 (20.82)
Comorbidities
",", n (%)94 (12.6)98 (13.0)Hyperte",TextQuoteSelector,TextPositionSelector,21667,21684,WS_DS,no,WS_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:55:24.872382+00:00
VR9P4sTMEemW34ehMcWgtQ,3NabqAPM,https://europepmc.org/articles/PMC4540425/,angiotensin receptor,"n converting enzyme inhibitors, "," blockers and diuretics.BII, BPH",TextQuoteSelector,TextPositionSelector,42342,42362,MIS_GP,yes,[MIS_GP][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T11:02:28.904304+00:00
UuCUpMTKEemUgj89wWhFlg,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Haemorrhagic cerebrovascular disorders,"isorder, n (%)97 (13.0)91 (12.1)",", n (%)7 (0.9)5 (0.7)Ischaemic c",TextQuoteSelector,TextPositionSelector,22110,22148,WS_DS,no,WS_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:48:06.059680+00:00
TSOG1sTIEemQYbMRrY-RgA,3NabqAPM,https://europepmc.org/articles/PMC4540425/,ED,oexisting erectile dysfunction (,"), with PDE-5 inhibitors and not",TextQuoteSelector,TextPositionSelector,12246,12248,MIS_DS,yes,[MIS_DS][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:33:37.615412+00:00
TJMNYMTLEemJT6-qx-5hYw,3NabqAPM,https://europepmc.org/articles/PMC4540425/,depression,s also evidence to suggest that ,", anxiety and somatization may i",TextQuoteSelector,TextPositionSelector,56468,56478,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:55:04.946015+00:00
SBSCEsTIEemUK7NQMjlxBA,3NabqAPM,https://europepmc.org/articles/PMC4540425/, erectile dysfunction , either alone or with coexisting,"(ED), with PDE-5 inhibitors and ",TextQuoteSelector,TextPositionSelector,12223,12245,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:33:29.041574+00:00
Qy-dEMTLEemuCzsw-ssH-w,3NabqAPM,https://europepmc.org/articles/PMC4540425/,CYP3A4 ,"dinediones, n (%)8 (1.1)10 (1.3)","Inhibitors, n (%)88 (11.8)101 (1",TextQuoteSelector,TextPositionSelector,24009,24016,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:54:49.121161+00:00
NcMDFsTKEemUNE-AHsZdQw,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Cardiovascular disorder,"order, n (%)309 (41.4)311 (41.4)",", n (%)342 (45.8)344 (45.7)Renov",TextQuoteSelector,TextPositionSelector,22497,22520,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:47:17.205364+00:00
NRHXosTLEemTdqPqj_Z6SA,3NabqAPM,https://europepmc.org/articles/PMC4540425/, cerebrovascular diseases,"cardiovascular diseases, cluster",", cluster anti-hypertensive drug",TextQuoteSelector,TextPositionSelector,24461,24486,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:54:25.550527+00:00
N99ZfMTMEemgj2v1VL9b8g,3NabqAPM,https://europepmc.org/articles/PMC4540425/,angiotensin converting enzyme,"ers, calcium channels blockers, "," inhibitors, angiotensin recepto",TextQuoteSelector,TextPositionSelector,42300,42329,MIS_GP,yes,[MIS_GP][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T11:01:39.889831+00:00
L4akVMTOEem9M_NZ9fAepg,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Renovascular disorder,"order, n (%)342 (45.8)344 (45.7)",", n (%)0 (0)0 (0)Renal impairmen",TextQuoteSelector,TextPositionSelector,22547,22568,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T11:15:44.740115+00:00
JzOz2sTLEemw2QOLh8sIAg,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Myocardial infarction ," (95% CI)

IPSS QoL improvement
","(Y/N)2 (0, 5)100 (97, 100)Smokin",TextQuoteSelector,TextPositionSelector,40731,40753,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:54:02.194463+00:00
Ja-xQMTKEemzdfu_AK-nkQ,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Cardiomyopathy,"iac failure, n (%)6 (0.8)5 (0.7)",", n (%)0 (0)1 (0.1)Other cardiac",TextQuoteSelector,TextPositionSelector,21986,22000,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:46:50.293668+00:00
JPg6rsTMEemlZq-5pqNgNQ,3NabqAPM,https://europepmc.org/articles/PMC4540425/,albumin,)39.26 (12.07)39.70 (11.09)Mean ," (SD), g/dl4.22 (0.33)4.21 (0.32",TextQuoteSelector,TextPositionSelector,21534,21541,MIS_GP,yes,[MIS_GP][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T11:01:08.140200+00:00
I-5y1MTOEemZCAtztYPnOQ,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Renal impairment I,"seline)*
91 (59, 100)47 (39, 54)","100 (72, NaN)32 (25, 39)Open in ",TextQuoteSelector,TextPositionSelector,43923,43941,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T11:15:25.361361+00:00
HXvomsTKEemwqfeABDN6vA,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Cardiac failure,"rrhythmia, n (%)41 (5.5)32 (4.3)",", n (%)6 (0.8)5 (0.7)Cardiomyopa",TextQuoteSelector,TextPositionSelector,21950,21965,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:46:36.513266+00:00
GTVHhMTMEemuFh-VJNUMXw,3NabqAPM,https://europepmc.org/articles/PMC4540425/,5-α-reductase ,"sants (Y/N)98 (94, 100)5 (2, 10)","inhibitors (Y/N)99 (96, 100)2 (0",TextQuoteSelector,TextPositionSelector,37131,37145,MIS_GP,yes,[MIS_GP][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T11:00:48.349005+00:00
Enl4nsTLEemQZ8fi3fMsrw,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Hyperlipidemia,"ase (Y/N)*66 (59, 74)46 (37, 55)"," (Y/N)81 (74, 87)29 (22, 38)IPSS",TextQuoteSelector,TextPositionSelector,41231,41245,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:53:27.687191+00:00
EEMAOMTOEemHKBOcYVh9Jw,3NabqAPM,https://europepmc.org/articles/PMC4540425/,phosphodiesterase type 5,"l 5mg once daily, a long-acting "," (PDE-5) inhibitor, initially in",TextQuoteSelector,TextPositionSelector,12029,12053,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T11:14:52.444080+00:00
DeuEQsTMEemVkI_LOk26EQ,3NabqAPM,https://europepmc.org/articles/PMC4540425/,5-α reductase,he use of α-blocking agents and ," inhibitors, either alone or in ",TextQuoteSelector,TextPositionSelector,11738,11751,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T11:00:29.402833+00:00
D0vynMTKEemY87dH5sEf5A,3NabqAPM,https://europepmc.org/articles/PMC4540425/,cardiac disorders,"yopathy, n (%)0 (0)1 (0.1)Other ",", n (%)19 (2.5)25 (3.3)Any cardi",TextQuoteSelector,TextPositionSelector,22025,22042,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:46:12.409143+00:00
Cfu8bsTKEem3MSMwLdtWaA,3NabqAPM,https://europepmc.org/articles/PMC4540425/,cardiac disorder,"rders, n (%)19 (2.5)25 (3.3)Any ",", n (%)97 (13.0)91 (12.1)Haemorr",TextQuoteSelector,TextPositionSelector,22069,22085,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:46:03.861056+00:00
BdwM8sTOEemkN-ND9IL5AA,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Incretin,"mylin analogues, n (%)0 (0)0 (0)"," mimetics, n (%)0 (0)2 (0.3Dipep",TextQuoteSelector,TextPositionSelector,23815,23823,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T11:14:34.848754+00:00
Ak6GFsTMEemuE8P74rcLuw,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Vasculitis,"aemia, n (%)152 (20.3)183 (24.3)",", n (%)0 (0)3 (0.4)Ischaemic hea",TextQuoteSelector,TextPositionSelector,21790,21800,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T11:00:09.742647+00:00
9q36-MTLEemkdPNIeYU4Uw,3NabqAPM,https://europepmc.org/articles/PMC4540425/, TRT , 106 variables. The inclusion of,"as a variable, which is implicit",TextQuoteSelector,TextPositionSelector,24688,24693,WT_GP,no,[WT_GP],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:59:50.568996+00:00
8u4NdMTJEem_6hOi5BAYIg,3NabqAPM,https://europepmc.org/articles/PMC4540425/,hypogonadism,ts of tadalafil 5mg in men with , and LUTS-BPH showed that while ,TextQuoteSelector,TextPositionSelector,56185,56197,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:45:25.254469+00:00
7AS38MTKEemNbbNXvuyepg,3NabqAPM,https://europepmc.org/articles/PMC4540425/,cardiovascular diseases," cerebrovascular drugs, cluster ",", cluster cerebrovascular diseas",TextQuoteSelector,TextPositionSelector,24429,24452,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:52:23.088065+00:00
6FLsmMTLEemmvzdPXLkOVg,3NabqAPM,https://europepmc.org/articles/PMC4540425/,SHBG,n sex hormone binding globulin (,) (SD) nmol/l40.37 (21.21)41.02 ,TextQuoteSelector,TextPositionSelector,21609,21613,CRT_GP,yes,[CRT_GP][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:59:26.477180+00:00
5tphmsTJEemka0PwuKzUyg,3NabqAPM,https://europepmc.org/articles/PMC4540425/, anxiety,"ence to suggest that depression,", and somatization may influence ,TextQuoteSelector,TextPositionSelector,56479,56487,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:45:04.969962+00:00
4AGnPMTLEem_41_lAYXiiA,3NabqAPM,https://europepmc.org/articles/PMC4540425/,sex hormone binding globulin, g/dl4.22 (0.33)4.21 (0.32)Mean , (SHBG) (SD) nmol/l40.37 (21.21),TextQuoteSelector,TextPositionSelector,21579,21607,CRT_GP,yes,[CRT_GP][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:59:12.402912+00:00
3LB0UsTJEem_6Yuurfjwgg,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Angiotensin converting enzyme,"blockers, n (%)76 (10.2)68 (9.0)"," inhibitors, n (%)125 (16.7)146 ",TextQuoteSelector,TextPositionSelector,23016,23045,WS_GP,yes,[WS_GP][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:44:47.901789+00:00
2NxREMTKEemMqrdxPK7AZA,3NabqAPM,https://europepmc.org/articles/PMC4540425/, Renal impairment II,"eline) = 2%; Renal impairment I,",", Renal impairment I (≥80), Rena",TextQuoteSelector,TextPositionSelector,25307,25327,WS_DS,yes,[WS_DS][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:51:50.992152+00:00
1RIkPsTJEemhHisb2Ewvqg,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Angiotensin receptor,"itors, n (%)125 (16.7)146 (19.4)"," blockers, n (%)90 (12.0)80 (10.",TextQuoteSelector,TextPositionSelector,23083,23103,WS_GP,yes,[WS_GP][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:44:35.176483+00:00
0uXM8MTKEemUNg81ai7QKQ,3NabqAPM,https://europepmc.org/articles/PMC4540425/, Renal impairment I, = 14%; Albumin (baseline) = 2%;,", Renal impairment II, Renal imp",TextQuoteSelector,TextPositionSelector,25287,25306,WS_DS,yes,[WS_DS][ALL],,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:51:40.914082+00:00
0IQPFsTLEemW16cfKYo5Ig,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Renal impairment stage II ,R ≥90) n (%)199 (26.8)228 (30.6),(GFR 60–89) n (%)327 (44.0)368 (,TextQuoteSelector,TextPositionSelector,22709,22735,WS_DS,no,WS_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:58:46.537785+00:00
-mY1lsTNEem95r_SDVvM7g,3NabqAPM,https://europepmc.org/articles/PMC4540425/,Cardiac arrhythmia,"nfarction, n (%)11 (1.5)11 (1.5)",", n (%)41 (5.5)32 (4.3)Cardiac f",TextQuoteSelector,TextPositionSelector,21909,21927,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T11:14:15.662103+00:00
-3B0vsTJEemJSd9FOdG7Tw,3NabqAPM,https://europepmc.org/articles/PMC4540425/,somatization,"st that depression, anxiety and ", may influence the clinical mani,TextQuoteSelector,TextPositionSelector,56492,56504,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.,2019-08-22T10:45:39.449501+00:00
